Cancer research activity in the Arab world: a 15-year bibliometric analysis.

Marc Machaalani, Jad El Masri, Lemir Majed El Ayoubi, Bassam Matar
{"title":"Cancer research activity in the Arab world: a 15-year bibliometric analysis.","authors":"Marc Machaalani,&nbsp;Jad El Masri,&nbsp;Lemir Majed El Ayoubi,&nbsp;Bassam Matar","doi":"10.1186/s42506-022-00120-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Arab region comprises 22 countries located in the Middle East and North Africa, sharing cultural and linguistic ties. Arab countries have continued to lag in terms of biomedical research compared to other nations for several past decades. Cancer is a major public health concern, being the second leading cause of death globally. Given that high research activity on cancer reflects positively on screening programs, awareness, and clinical practice, this article aimed to examine the activity and trend of cancer research in the Arab world between 2005 and 2019.</p><p><strong>Methods: </strong>Between 2005 and 2019, the number of cancer-related articles published by each Arab country, and regarding 27 different types, was assessed using the PubMed database. Numbers were normalized with respect to each country's average population and average Gross Domestic Product (GDP).</p><p><strong>Results: </strong>Arab countries contributed to 1.52% of total cancer publications. The number of cancer publications has steadily grown since 2005, with the last 7 years alone witnessing 75.69% of the total Arab cancer-related publications. In terms of publications per million persons, Qatar ranked first (393.74 per million persons), while in terms of publications per national GDP, Egypt ranked first (464.27 per billion US dollars). Breast, liver, and colorectal cancers had the highest numbers of all Arab cancer-related publications, while testicular, vulvar, and gallbladder cancers had the least.</p><p><strong>Conclusions: </strong>This paper pools information and insight for scientists, clinicians, funders, and decision-makers on the actualities and developments of cancer research in the Arab world. Addressing the barriers facing cancer research remains a cornerstone in the plan to improve the Arab world's output and contribution to the field of oncology.</p>","PeriodicalId":22819,"journal":{"name":"The Journal of the Egyptian Public Health Association","volume":" ","pages":"26"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669254/pdf/","citationCount":"10","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of the Egyptian Public Health Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s42506-022-00120-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Nursing","Score":null,"Total":0}
引用次数: 10

Abstract

Background: The Arab region comprises 22 countries located in the Middle East and North Africa, sharing cultural and linguistic ties. Arab countries have continued to lag in terms of biomedical research compared to other nations for several past decades. Cancer is a major public health concern, being the second leading cause of death globally. Given that high research activity on cancer reflects positively on screening programs, awareness, and clinical practice, this article aimed to examine the activity and trend of cancer research in the Arab world between 2005 and 2019.

Methods: Between 2005 and 2019, the number of cancer-related articles published by each Arab country, and regarding 27 different types, was assessed using the PubMed database. Numbers were normalized with respect to each country's average population and average Gross Domestic Product (GDP).

Results: Arab countries contributed to 1.52% of total cancer publications. The number of cancer publications has steadily grown since 2005, with the last 7 years alone witnessing 75.69% of the total Arab cancer-related publications. In terms of publications per million persons, Qatar ranked first (393.74 per million persons), while in terms of publications per national GDP, Egypt ranked first (464.27 per billion US dollars). Breast, liver, and colorectal cancers had the highest numbers of all Arab cancer-related publications, while testicular, vulvar, and gallbladder cancers had the least.

Conclusions: This paper pools information and insight for scientists, clinicians, funders, and decision-makers on the actualities and developments of cancer research in the Arab world. Addressing the barriers facing cancer research remains a cornerstone in the plan to improve the Arab world's output and contribution to the field of oncology.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阿拉伯世界的癌症研究活动:15年文献计量分析。
背景:阿拉伯地区包括位于中东和北非的22个国家,共享文化和语言联系。过去几十年来,阿拉伯国家在生物医学研究方面一直落后于其他国家。癌症是一个重大的公共卫生问题,是全球第二大死亡原因。鉴于高水平的癌症研究活动对筛查项目、意识和临床实践都有积极的影响,本文旨在研究2005年至2019年阿拉伯世界癌症研究的活动和趋势。方法:在2005年至2019年期间,使用PubMed数据库评估每个阿拉伯国家发表的27种不同类型的癌症相关文章的数量。这些数字是根据每个国家的平均人口和平均国内生产总值(GDP)进行标准化的。结果:阿拉伯国家占癌症出版物总数的1.52%。自2005年以来,癌症出版物的数量稳步增长,仅过去7年就占阿拉伯癌症相关出版物总数的75.69%。在每百万人的出版物方面,卡塔尔排名第一(393.74 /百万人),而在每国民生产总值的出版物方面,埃及排名第一(464.27 /十亿美元)。在所有阿拉伯癌症相关出版物中,乳腺癌、肝癌和结直肠癌的数量最多,而睾丸癌、外阴癌和胆囊癌的数量最少。结论:本文为科学家、临床医生、资助者和决策者提供了关于阿拉伯世界癌症研究现状和发展的信息和见解。解决癌症研究面临的障碍仍然是提高阿拉伯世界对肿瘤学领域的产出和贡献的计划的基石。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.50
自引率
0.00%
发文量
25
审稿时长
10 weeks
期刊介绍: The journal accepts papers of original research which are not being considered for publication elsewhere and which contribute to the advancement of knowledge of Public Health at large
期刊最新文献
Metabolic syndrome prediction based on body composition indices. Pattern of antibiotic use among children caregivers: a cross-sectional study. Correction: Framework for developing cost-effectiveness analysis threshold: the case of Egypt. Psychological antecedents of vaccine inequity: keys to improve the rates of vaccination. Matters arising: On the cost-effectiveness for the Italian National Health Service of nab-paclitaxel plus gemcitabine vs gemcitabine alone in metastatic pancreatic cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1